| 1 |
Upadhyaya S, Brown A, Cheslack-Postava K, Gissler M, Gyllenberg D, Heinonen E, Laitinen J, McKeague I, Hinkka-Yli-Salomäki S, Sourander A, Tornio A, Malm H. Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: a review of the literature and description of a study protocol for a register-based cohort study. Reprod Toxicol 2023;:108365. [PMID: 36958464 DOI: 10.1016/j.reprotox.2023.108365] [Reference Citation Analysis]
|
| 2 |
Bezenah JC, Tejada AN, Garcia DA, Lopez K, Richie JA, Amodeo DA, Amodeo LR. Early prenatal and late prenatal escitalopram exposure differentially impacts behavioral flexibility and anxiety-related behaviors in adulthood. Pharmacol Biochem Behav 2023;224:173534. [PMID: 36889444 DOI: 10.1016/j.pbb.2023.173534] [Reference Citation Analysis]
|
| 3 |
Zanni G, Van Dijk M, Cagliostro MC, Stevens GS, Pini N, Rose AL, Kesin AL, Lugo-candelas C, Goncalves PD, Mackay AS, Kulkarni P, Ferris CF, Weissman MM, Talati A, Ansorge MS, Gingrich JA. Perinatal SSRI Exposure Impacts Innate Fear Circuit Activation and Behavior in Mice and Humans.. [DOI: 10.1101/2023.03.01.23286641] [Reference Citation Analysis]
|
| 4 |
Lozano AFQ, Moura MS, Dinhani TRB, Valencise L, De Grava Kempinas W. Is lactational sertraline exposure safe for maternal health and the reproductive/neurobehavioral development of the descendants? A study in rats. Reprod Toxicol 2023;117:108356. [PMID: 36828160 DOI: 10.1016/j.reprotox.2023.108356] [Reference Citation Analysis]
|
| 5 |
Hutchison SM, Brain U, Grunau RE, Kuzeljevic B, Irvine M, Mâsse LC, Oberlander TF. Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study. BJPsych Open 2023;9:e26. [PMID: 36721917 DOI: 10.1192/bjo.2022.623] [Reference Citation Analysis]
|
| 6 |
Yan Y, Park DI, Horn A, Golub M, Turck CW. Delineation of biomarkers and molecular pathways of residual effects of fluoxetine treatment in juvenile rhesus monkeys by proteomic profiling. Zool Res 2023;44:30-42. [PMID: 36266933 DOI: 10.24272/j.issn.2095-8137.2022.196] [Reference Citation Analysis]
|
| 7 |
Inkster AM, Konwar C, Peñaherrera MS, Brain U, Khan A, Price EM, Schuetz JM, Portales-Casamar É, Burt A, Marsit CJ, Vaillancourt C, Oberlander TF, Robinson WP. Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy. Sci Rep 2022;12:22576. [PMID: 36585414 DOI: 10.1038/s41598-022-26071-8] [Reference Citation Analysis]
|
| 8 |
Linhares SSG, Meurer YDSR, de Aquino ACQ, Câmara DA, Brandão LEM, Fiuza FP, Lima RH, Engelberth RCJG, Cavalcante JS. Prenatal exposure to fluoxetine modulates emotionality and aversive memory in male and female rat offspring. Behav Pharmacol 2022;33:575-88. [PMID: 36256730 DOI: 10.1097/FBP.0000000000000705] [Reference Citation Analysis]
|
| 9 |
Laureano-Melo R, Dos-Santos RC, da Conceição RR, de Souza JS, da Silva Almeida C, Reis LC, Marinho BG, Giannocco G, Ahmed RG, da Silva Côrtes W. Neonatal D-fenfluramine treatment promotes long-term behavioral changes in adult mice. Int J Dev Neurosci 2022. [PMID: 35718760 DOI: 10.1002/jdn.10204] [Reference Citation Analysis]
|
| 10 |
Li H, Fernández-Guasti A, Xu Y, Swaab D. Retracted: Sexual orientation, neuropsychiatric disorders and the neurotransmitters involved. Neurosci Biobehav Rev 2021;131:479-88. [PMID: 34597715 DOI: 10.1016/j.neubiorev.2021.09.048] [Reference Citation Analysis]
|
| 11 |
Lu Q, Xiang H, Zhu H, Chen Y, Lu X, Huang C. Intranasal lipopolysaccharide administration prevents chronic stress-induced depression- and anxiety-like behaviors in mice. Neuropharmacology 2021;200:108816. [PMID: 34599975 DOI: 10.1016/j.neuropharm.2021.108816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Mireia V, Kristína C, Eva Š, Ezster B, Eduard U, Michal D, Kristína B. Sex- and age- dependent effect of pre-gestational chronic stress and mirtazapine treatment on neurobehavioral development of offspring.. [DOI: 10.1101/2021.08.04.455108] [Reference Citation Analysis]
|
| 13 |
Meador KJ, Cohen MJ, Loring DW, May RC, Brown C, Robalino CP, Matthews AG, Kalayjian LA, Gerard EE, Gedzelman ER, Penovich PE, Cavitt J, Hwang S, Sam M, Pack AM, French J, Tsai JJ, Pennell PB; Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Investigator Group. Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study. JAMA Neurol 2021;78:927-36. [PMID: 34096986 DOI: 10.1001/jamaneurol.2021.1583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 14 |
Vuong HE, Coley EJL, Kazantsev M, Cooke ME, Rendon TK, Paramo J, Hsiao EY. Interactions between maternal fluoxetine exposure, the maternal gut microbiome and fetal neurodevelopment in mice. Behav Brain Res 2021;410:113353. [PMID: 33979656 DOI: 10.1016/j.bbr.2021.113353] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
